These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2148674)

  • 21. Increased incidence of murine graft-versus-host disease after allogeneic bone marrow transplantation by previous infusion of syngeneic bone marrow cells.
    Waer M; Ang KK; van der Schueren E; Vandeputte M
    Transplantation; 1984 Oct; 38(4):396-400. PubMed ID: 6238457
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of stable chimerism and transplantation tolerance to rat islet and heart allografts by ultraviolet-B modulation of bone marrow cells.
    Jin MX; Engelstad K; Oluwole SF
    Transplantation; 1992 Jul; 54(1):113-8. PubMed ID: 1385914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of effector cells of graft vs leukemia following allogeneic bone marrow transplantation in mice inoculated with murine B-cell leukemia.
    Weiss L; Weigensberg M; Morecki S; Bar S; Cobbold S; Waldmann H; Slavin S
    Cancer Immunol Immunother; 1990; 31(4):236-42. PubMed ID: 2379219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Graft-versus-leukemia activity after bone marrow transplantation does not require graft-versus-host disease.
    Glass B; Uharek L; Gassmann W; Focks B; Bolouri H; Loeffler H; Mueller-Ruchholtz W
    Ann Hematol; 1992 Jun; 64(6):255-9. PubMed ID: 1637877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies of immunologic tolerance to host minor histocompatibility antigens following allogeneic bone marrow transplantation in mice.
    Perreault C; Allard A; Brochu S; Poupart C; Fontaine P; Bélanger R; Gyger M
    Bone Marrow Transplant; 1990 Aug; 6(2):127-35. PubMed ID: 2145050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of lethal graft-versus-host disease in mice by monoclonal antibodies directed against T cells or their subsets. I. Evidence for the induction of a state of tolerance based on suppression.
    Knulst AC; Tibbe GJ; Noort WA; Bril-Bazuin C; Benner R; Savelkoul HF
    Bone Marrow Transplant; 1994 Mar; 13(3):293-301. PubMed ID: 8199571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tolerance, immunocompetence, and secondary disease in fully allogeneic radiation chimeras.
    Rayfield LS; Brent L
    Transplantation; 1983 Aug; 36(2):183-9. PubMed ID: 6349042
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of the additional injection of host-type bone marrow on the immune tolerance of minor antigen-mismatched chimeras: possible involvement of double-negative (natural killer) T cells.
    Sefrioui H; Billiau AD; Overbergh L; Rutgeerts O; Waer M
    Transplantation; 1999 Nov; 68(10):1560-7. PubMed ID: 10589955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo administration of interleukin-6 in murine allogeneic bone marrow chimeras: early and delayed enhancement of hematopoiesis accompanied with split tolerance but not with graft-versus-host disease.
    Imamura M; Hashino S; Kobayashi H; Tanaka J; Imai K; Han M; Fujii Y; Kobayashi M; Higa T; Kasai M
    Immunobiology; 1994 Jun; 190(4-5):346-67. PubMed ID: 7982720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allosuppressor and allohelper T cells in acute and chronic graft-vs-host disease. V. F1 mice with secondary chronic GVHD contain F1-reactive allohelper but no allosuppressor T cells.
    Pals ST; Gleichmann H; Gleichmann E
    J Exp Med; 1984 Feb; 159(2):508-23. PubMed ID: 6229596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leucyl-leucine methyl ester treatment of donor cells permits establishment of immunocompetent parent----F1 chimeras that are selectively tolerant of host alloantigens.
    Thiele DL; Calomeni JA; Lipsky PE
    J Immunol; 1987 Oct; 139(7):2137-42. PubMed ID: 3309052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effective graft-versus-leukemia effects independent of graft-versus-host disease after T cell-depleted allogeneic bone marrow transplantation in a murine model of B cell leukemia/lymphoma. Role of cell therapy and recombinant IL-2.
    Weiss L; Lubin I; Factorowich I; Lapidot Z; Reich S; Reisner Y; Slavin S
    J Immunol; 1994 Sep; 153(6):2562-7. PubMed ID: 8077666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The requirement for allogeneic chimerism for second transfer of tolerance from mixed allogeneic chimeras (A+B-->A) to secondary recipients.
    Wren SM; Hronakes ML; Ildstad ST
    Transplantation; 1992 Dec; 54(6):1031-40. PubMed ID: 1465769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of tolerance in murine radiation bone marrow chimeras. I. Nonspecific suppression of alloreactivity by spleen cells from early, but not late, chimeras.
    Auchincloss H; Sachs DH
    Transplantation; 1983 Oct; 36(4):436-41. PubMed ID: 6226136
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of the immune response in experimental models of autoimmune disorders: resistance of (NZB X NZW)F1 mice to tolerance induction in vivo.
    Zan-Bar I; Barzilay M; Moscovitch M; Slavin S
    Clin Exp Immunol; 1983 Mar; 51(3):558-64. PubMed ID: 6851246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allogeneic cell therapy in murine B-cell leukemia (BCL1): 1. Alloimmune-mediated graft-versus-leukemia (GVL) effects induced by unmodified and in vitro rIL-2-activated bone marrow and lymphocytes from different lymphoid compartments.
    Weiss L; Reich S; Slavin S
    Cytokines Cell Mol Ther; 1999 Sep; 5(3):145-52. PubMed ID: 10641572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of cyclosporine A and methylprednisolone on the graft-versus-leukemia effects across major histocompatibility barriers in mice following allogeneic bone marrow transplantation.
    Weiss L; Reich S; Slavin S
    Bone Marrow Transplant; 1990 Oct; 6(4):229-33. PubMed ID: 2085696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S
    Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Strong T cell tolerance in parent----F1 bone marrow chimeras prepared with supralethal irradiation. Evidence for clonal deletion and anergy.
    Gao EK; Lo D; Sprent J
    J Exp Med; 1990 Apr; 171(4):1101-21. PubMed ID: 2139098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of host lymphoid cells in antibody-facilitated bone marrow chimeras.
    McCarthy SA; Griffith IJ; Gambel P; Francescutti LH; Wegmann TG
    Transplantation; 1985 Jul; 40(1):12-7. PubMed ID: 3892791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.